Andreas Carlsson
Lund, M 22100, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
The chaperone DNAJB6b halts amyloid formation through association with transient Aβ oligomers.
Journal: Physical chemistry chemical physics : PCCP
Published: May 01, 2026
Human chaperone DNAJB6b suppresses tau fibril formation through co-aggregation.
Journal: Communications chemistry
Published: January 26, 2026
Solubility and Metastability of the Amyloidogenic Core of Tau.
Journal: ACS chemical neuroscience
Published: January 23, 2026
Effects of solution conditions on the self-assembly of the chaperone protein DNAJB6b.
Journal: Communications chemistry
Published: June 17, 2025
On the thermal and chemical stability of DNAJB6b and its globular domains.
Journal: Biophysical chemistry
Published: December 03, 2024
The Ability of DNAJB6b to Suppress Amyloid Formation Depends on the Chaperone Aggregation State.
Journal: ACS chemical neuroscience
Published: April 19, 2024
The C-terminal domain of the antiamyloid chaperone DNAJB6 binds to amyloid-β peptide fibrils and inhibits secondary nucleation.
Journal: The Journal of biological chemistry
Published: March 21, 2023
Long-term risk of major adverse cardiovascular events following ischemic stroke or TIA.
Journal: Scientific reports
Published: August 03, 2022
Prediction of designer drugs: Synthesis and spectroscopic analysis of synthetic cathinone analogs that may appear on the Swedish drug market.
Journal: Drug testing and analysis
Published: August 14, 2017
Prediction of designer drugs: synthesis and spectroscopic analysis of synthetic cannabinoid analogues of 1H-indol-3-yl(2,2,3,3-tetramethylcyclopropyl)methanone and 1H-indol-3-yl(adamantan-1-yl)methanone.
Journal: Drug testing and analysis
Published: March 08, 2015
Showing 1-11 of 11
Last Updated: 09/26/2026